ASX-listed medications adherence solution developer MedAdvisor has raised $17 million to fund its further expansion into new markets, with Texan firm HMS Holdings investing $11m and becoming the Australian company's largest shareholder.

Funds raised will be used to accelerate international expansion through MedAdvisor’s partnering strategies in the US, southeast Asia and the UK, as well as domestic growth and technology development in advance of the legislative change to electronic prescribing.